NOTCH3 and neoplasm: NOTCH3-KO (PE04-NOTCH3-KO cells 5 × 106 cell/mouse; i.p. injected) greatly reduced tumorigenesis by extending mouse survival to 161 ± 21 days, with tumor numbers and ascites volumes significantly lower than the control mice (Figure 7A and Table 1).